World Preclinical Congress 2017 | Need for Translational Methods in CNS Drug Discovery

Charles River offers early discovery phase efficacy testing for novel therapies aimed at neurological and psychiatric conditions. Using a full range of different animal models, we use translational methods including in vitro assays, behavioral and cognitive testing and imaging to accelerate the development of novel CNS and neurological disease related therapies. Multi-modal study designs are essential for robust preclinical data that translate to success in the clinic. For more information, please visit http://www.WorldPreClinicalCongress.com/Translational-Strategies-CNS/